Perot aligns with AMGA, MGMA for extension center EHR training

The American Medical Group Association (AMGA), the Medical Group Management Association (MGMA) and Perot Systems have formed an alliance to offer EHR-related training and implementation services to health IT regional extension centers.

According to the participants, the partnership will offer educational and technical services to organizations that are designated by the Department of Health and Human Services (HHS) to establish an extension center, allowing them to help physicians and healthcare organizations prepare for EHR implementation and meaningful use requirements.

The Health IT Regional Extension Program was created with the passage of the American Recovery and Reinvestment Act of 2009 (ARRA). Once established, the extension centers will provide technical assistance and disseminate best practices regarding health IT implementation. HHS plans to establish up to 70 extension centers, with the target being the least-advantaged providers struggling with implementation and adoption, including public and critical-access hospitals, Federally Qualified Healthcare Centers, rural providers and physician practices focused on primary care.

AMGA, MGMA and the Plano, Texas-based Perot said they will offer designated extension centers services, including:
  • Physician and healthcare organization targeting and outreach;
  • Incentive program and EHR-product education and awareness;
  • EHR subscription-based services;
  • Remote hosting services;
  • Health information exchange (HIE) services;
  • Remote implementation;
  • Remote training; and
  • A clinic-centric support desk.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.